* Information contained in this news release is current as of its date of announcement. Be aware that information contained herein is subject to change without notice.
June 24, 2019
National Cancer Center Japan
Mitsui Fudosan Co., Ltd.
Miraca Holdings Inc..
Tokyo, Japan, July 24, 2019 – Mitsui Fudosan Co., Ltd., a leading global real estate company headquartered in Tokyo, National Cancer Center Japan (Headquarters: Chuo-ku, Tokyo; President: Hitoshi Nakagama; hereinafter “NCC”), and Miraca Holdings Inc. (Headquarters: Shinjuku-ku, Tokyo; President & CEO Shigekazu Takeuchi; hereinafter “MiracaHD”) announced today that they have concluded a basic agreement on coordination and collaboration on development of next-generation medical technologies and healthcare services in the Kashiwa-no-ha area (Kashiwa City, Chiba Prefecture). With their tripartite collaboration to Cure and Conquer Cancer (“3C”), the three companies will now begin detailed discussions on specific initiatives.
The center for this initiative will be the Kashiwa-no-ha area in Kashiwa City, Chiba Prefecture, which has been built with the aim of realizing a smart city*1 through three urban development concepts: “A City of Health and Longevity,” “an Environmental Symbiotic City,” and “a City of New Industry Creation.”
The Kashiwa-no-ha area has a concentration of academic and research institutions, such as the National Cancer Center Hospital East and the Exploratory Oncology Research & Clinical Trial Center. An environment that produces new medical technologies and services is needed to serve as a testing ground for application of innovative seeds that lead to next-generation medical technologies. Creation of an environment where innovation can be supported through quality assurance and standardization of appropriate data and specimens based on a wealth of expertise is vital for the application of academic scholarship. Thus, to conquer and cure cancer, it is important to promote open innovation in the form of collaboration between industry, academia, and healthcare, and to advance research that adds “towns” to “industry, academia, and healthcare” through links with the local community and urban development. Conquering cancer requires coordinated efforts from the perspectives of medicine and the local community and urban development.
NCC, Mitsui Fudosan, and Miraca HD will each play an appropriate role aiming to achieve 3C. Mitsui Fudosan will coordinate and collaborate closely with its partners through the private-sector laboratory “Mitsui Link Lab Kashiwa-no-ha” (tentative name), which it is planning to set up in the area.
The three companies will use their respective strengths in close coordination and collaboration, carrying out the following roles. Their aim is to form a life science center in the Kashiwa-no-ha area, create next generation medical technologies and healthcare services in the area, and communicate and spread the results throughout not only Japan but also the world.
*1 The area around Kashiwa-no-ha Campus Station in Kashiwa City, Chiba Prefecture was chosen as a Smart City Model Project by the Ministry of Land, Infrastructure, Transport and Tourism on May 31, 2019.
At its Hospital East and the Exploratory Oncology Research & Clinical Trial Center on Kashiwa-no-ha Campus, NCC will provide consultation as needed to academic institutions and companies at Mitsui Link Lab Kashiwa-no-ha (tentative name) regarding communication of front-line medical needs and evaluation of new technologies, and so forth. Also, it will fulfill the role of an administrator to support research.
Mitsui Fudosan will “Location Establishment” for creating new industries, such as a wet lab capable of advanced research and creative offices. It will also promote innovation using community networks such as LINK-J*2 and 31Ventures*3 to provide support for ventures.
Miraca HD will undertake development provision and standardization of medical services including various kinds of testing, and provide seeds matching opportunities to help commercialize seeds.
*2 LINK-J is short for Life Science Innovation Network Japan, which supports exchanges between industry, academia, and government with a view to creating innovation in the life science field.
*3 31Ventures is a platform provided by Mitsui Fudosan for comprehensively supporting the growth of ventures based on “community,” “support” and “funding.”
|Address||6-6-1, Kashiwa-no-ha, Kashiwa City, Chiba Prefecture|
|Site area||Approx. 18,000 m2 (approx. 193,750 ft2)|
|Occupation date||2021 (Scheduled)|
|Access||Approximately six minutes by bus from the west exit of Kashiwanoha-campus Station, on the Tsukuba Express Line.|